Mineralys Therapeutics, Inc. (MLYS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$26
Day's range
$27.47

Mineralys Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CATALYS PACIFIC, LLC 05/14/2026 7.90 M $214.11 M   0.00% 11.68%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 7.69 M $208.40 M   5.04% 11.37%
SAMSARA BIOCAPITAL, LLC 05/15/2026 5.87 M $159.05 M   0.00% 8.68%
FMR LLC 05/15/2026 4.86 M $131.69 M   -3.88% 7.19%
BLACKROCK, INC. 05/13/2026 4.48 M $121.41 M   3.56% 6.62%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.36 M $91.00 M   328.31% 4.96%
STATE STREET CORP 05/15/2026 2.94 M $79.53 M   -7.82% 4.34%
CALIGAN PARTNERS LP 05/15/2026 2.77 M $75.11 M   0.00% 4.10%
05/15/2026 2.45 M $66.49 M   100.00% 3.63%
LAURION CAPITAL MANAGEMENT LP 05/14/2026 2.23 M $60.47 M   30.26% 3.30%
ORBIMED ADVISORS LLC 05/15/2026 2.05 M $55.61 M   109.39% 3.03%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.91 M $51.78 M   58.33% 2.83%
FRANKLIN RESOURCES INC 05/13/2026 1.78 M $48.35 M   -0.23% 2.64%
CAPTION MANAGEMENT, LLC 05/15/2026 1.75 M $47.44 M   43.33% 2.59%
ANDERA PARTNERS 05/11/2026 1.59 M $43.13 M   0.00% 2.35%
SR ONE CAPITAL MANAGEMENT, LP 05/14/2026 1.56 M $42.37 M   0.00% 2.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 1.54 M $41.68 M   0.00% 2.27%
CAPTION MANAGEMENT, LLC 05/15/2026 1.52 M $41.24 M   24.02% 2.25%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.50 M $40.66 M   7.11% 2.22%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.34 M $36.39 M   1.37% 1.99%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 1.34 M $36.30 M   198.43% 1.98%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.30 M $35.25 M   3.46% 1.92%
JENNISON ASSOCIATES LLC 05/06/2026 1.27 M $34.30 M   0.60% 1.87%
ARMISTICE CAPITAL, LLC 05/15/2026 1.18 M $31.86 M   73.96% 1.74%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.10 M $29.81 M   11.45% 1.63%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 1.03 M $28.02 M   21.29% 1.53%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 1.00 M $27.14 M   0.97% 1.48%
ALLIANCEBERNSTEIN L.P. 05/15/2026 975.96 K $35.42 M   5.79% 1.44%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 914.73 K $24.78 M   84.22% 1.35%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 895.48 K $24.26 M   690.47% 1.32%
D. E. SHAW & CO., INC. 05/15/2026 887.19 K $24.03 M   -22.90% 1.31%
AMERICAN CENTURY COMPANIES INC 05/15/2026 884.11 K $23.95 M   -2.64% 1.31%
MORGAN STANLEY 05/15/2026 849.18 K $23.00 M   32.79% 1.26%
CANDRIAM S.C.A. 04/30/2026 801.90 K $21.72 M   18.21% 1.19%
GOLDMAN SACHS GROUP INC 05/15/2026 785.04 K $21.27 M   -45.89% 1.16%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 750.00 K $20.32 M   2.74% 1.11%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 750.00 K $20.32 M   0.00% 1.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 725.90 K $19.66 M   27.17% 1.07%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 719.90 K $19.50 M   0.00% 1.06%
05/08/2026 706.66 K $19.14 M   100.00% 1.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 692.60 K $18.76 M   43.19% 1.02%
TUDOR INVESTMENT CORP ET AL 05/15/2026 655.60 K $17.76 M   22.38% 0.97%
TROLUCE CAPITAL ADVISORS LLC 05/15/2026 655.00 K $17.74 M   100.00% 0.97%
CITADEL ADVISORS LLC 05/15/2026 600.04 K $16.26 M   50.04% 0.89%
STEMPOINT CAPITAL LP 05/18/2026 533.38 K $14.45 M   83.89% 0.79%
MILLENNIUM MANAGEMENT LLC 05/15/2026 525.26 K $14.23 M   568.06% 0.78%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 500.00 K $13.55 M   100.00% 0.74%
DAVERN CAPITAL PARTNERS, LP 05/14/2026 447.15 K $12.11 M   112.28% 0.66%
22NW, LP 05/15/2026 444.33 K $12.04 M   24.00% 0.66%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 443.90 K $12.03 M   -3.77% 0.66%

Mineralys Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 250 institutional investors and hedge funds held shares of Mineralys Therapeutics Inc. The most heavily invested institutionals were:

Catalys Pacific, LLC: 7.9 M

RA CAPITAL MANAGEMENT, L.P.: 7.69 M

Samsara BioCapital, LLC: 5.87 M

FMR LLC: 4.86 M

BlackRock, Inc.: 4.48 M

WELLINGTON MANAGEMENT GROUP LLP: 3.36 M

133.51% of Mineralys Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 93.50 M shares in the last 24 months. This purchase volume represents approximately $2.55 B in transactions.